{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:10:00Z","timestamp":1760782200518,"version":"3.41.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1023\/a:1011956502082","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T11:29:09Z","timestamp":1040642949000},"page":"147-157","source":"Crossref","is-referenced-by-count":9,"title":["Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome"],"prefix":"10.1007","volume":"68","author":[{"given":"Vahit","family":"Ozmen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neslihan","family":"Cabioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Dolay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Bilir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Kecer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Aydiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmut","family":"Muslumanoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Igci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yavuz","family":"Bozfakioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Temel","family":"Dagoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"355954_CR1","first-page":"153","volume":"1","author":"M Lippman","year":"1986","unstructured":"Lippman M, Sorace R, Bagley C, Danforth D Jr., Lichter A, Wesley M: Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery. NCI Monogr 1: 153-159, 1986","journal-title":"NCI Monogr"},{"key":"355954_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1634\/theoncologist.1-1-8","volume":"1","author":"V Valero","year":"1996","unstructured":"Valero V, Buzdar A, Hortobagyi G: Locally advanced breast cancer. Oncologist 1: 8-17, 1996","journal-title":"Oncologist"},{"key":"355954_CR3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.1992.10.6.1014","volume":"10","author":"IA Jaiyesimi","year":"1992","unstructured":"Jaiyesimi IA, Buzdar AU, Hortobagyi G: Inflammatory breast cancer: a review. J Clin Oncol 10: 1014-1024, 1992","journal-title":"J Clin Oncol"},{"key":"355954_CR4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/1097-0142(197203)29:3<545::AID-CNCR2820290302>3.0.CO;2-Q","volume":"29","author":"G Fletcher","year":"1972","unstructured":"Fletcher G: Local results of irradiation in the primary management of localized breast cancer. Cancer 29: 545-551, 1972","journal-title":"Cancer"},{"key":"355954_CR5","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/1097-0142(197603)37:3<1422::AID-CNCR2820370325>3.0.CO;2-Y","volume":"37","author":"R Zucali","year":"1976","unstructured":"Zucali R, Uslenghi C, Kenda R, Bonadonna G: Natural history and survival of inoperable breast cancer treated with radiotherapy followed by radical mastectomy. Cancer 37: 1422-1431, 1976","journal-title":"Cancer"},{"key":"355954_CR6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/978-3-642-74728-1_22","volume-title":"High-risk Breast Cancer","author":"G Hortobagyi","year":"1991","unstructured":"Hortobagyi G, Buzdar A: Locally advanced breast cancer: a review including the M.D. Anderson experience. In: Ragaz J, Ariel I (eds) High-risk Breast Cancer. Springer-Verlag, Berlin, 1991, pp 382-415"},{"key":"355954_CR7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0039-6109(05)70446-1","volume":"76","author":"KK Hunt","year":"1996","unstructured":"Hunt KK, Ames FC, Singletary SE, Buzdar AA, Hortobagyi GN: Locally advanced noninflammatory breast cancer. Surg Clin North Am 76: 393-410, 1996","journal-title":"Surg Clin North Am"},{"key":"355954_CR8","first-page":"585","volume-title":"Diseases of the Breast","author":"G Hortobagyi","year":"2000","unstructured":"Hortobagyi G, Singletary S, McNeese M: Treatment of locally advanced and inflammatory breast cancer. In: Harris J, Lippman M, Marrow M, Hellan S (eds) Diseases of the Breast. Philadelphia, Lippincott-Raven, 2000, pp 585-599"},{"key":"355954_CR9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1055-3207(18)30426-5","volume":"4","author":"AU Buzdar","year":"1995","unstructured":"Buzdar AU, Singletary SE, Booser DJ, Frye DK, Wasaff B, Hortobagyi GN: Combined modality treatment of stage III and inflammatory breast cancer: M.D. Anderson Cancer Center Experience. Surg Oncol Clin North Am 4: 715-734, 1995","journal-title":"Surg Oncol Clin North Am"},{"key":"355954_CR10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1200\/JCO.1990.8.8.1321","volume":"8","author":"R Silvestrini","year":"1990","unstructured":"Silvestrini R, Daidone MG, Valagussa P, Di Fronzo G, Mezzanotte G, Mariani M, Bonadonna G: 3H-thymidinelabeling index as a prognostic indicator in node-positive breast cancer. J Clin Oncol 8: 1321-1326, 1990","journal-title":"J Clin Oncol"},{"key":"355954_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1524-4741.1998.410041.x","volume":"4","author":"A Igci","year":"1998","unstructured":"Igci A, Berber E, Muslumano\u011flu M, Bilir A, Ozmen V, G\u00fcloglu R, Bozfakioglu Y, Dagoglu T, Kecer M: Thymidine labeling index in breast cancer prognosis. Breast J 4: 41-48, 1998","journal-title":"Breast J"},{"key":"355954_CR12","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1046\/j.1365-2168.1999.01248.x","volume":"86","author":"Y Nio","year":"1999","unstructured":"Nio Y, Tamura K, Kan N, Inamoto T, Ohgaki K, Kodama H: In vitro DNA synthesis in freshly separated human breast cancer cells assessed by tritiated thymidine incorporation assay: relationship to the long-term outcome of patients. Br J Surg 86: 1463-1469, 1999","journal-title":"Br J Surg"},{"key":"355954_CR13","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/1097-0142(19950915)76:6<1009::AID-CNCR2820760615>3.0.CO;2-8","volume":"76","author":"JW Gamel","year":"1995","unstructured":"Gamel JW, Meyer LS, Province MA: Proliferative rate of S-phase measurement may affect cure of breast carcinoma. Cancer 76: 1009-1018, 1995","journal-title":"Cancer"},{"key":"355954_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1006344010050","volume":"59","author":"WH Goodson","year":"2000","unstructured":"Goodson WH, Moore DH, Ljung BM, Chew K, Mayall B, Smith HS, Waldman FM: The prognostic value of proliferation indices: a study with in vivo bromodeoxyuuridine and Ki-67. Breast Cancer Res Treat 59: 113-123, 2000","journal-title":"Breast Cancer Res Treat"},{"key":"355954_CR15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1023\/A:1006140629766","volume":"51","author":"D Amadori","year":"1998","unstructured":"Amadori D, Silvestrini R: Prognostic and predictive value of thymidine labelling index in breast cancer. Breast Cancer Res Treat 51: 267-281, 1998","journal-title":"Breast Cancer Res Treat"},{"key":"355954_CR16","first-page":"375","volume":"71","author":"R Silvestrini","year":"1987","unstructured":"Silvestrini R, Daidone MG, Valagussa P, Salvadori B, Rovini D, Bonadonna G: Cell kinetics as a prognostic marker in locally advanced breast cancer. Cancer Treat Rep 71: 375-379, 1987","journal-title":"Cancer Treat Rep"},{"key":"355954_CR17","first-page":"383","volume":"62","author":"P Bonnier","year":"1995","unstructured":"Bonnier P, Charpin C, Lejeune C, Romain S, Tubiana N, Beedassy B, Martin PM, Serment H, Piana L: Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition? Int J Cancer 62: 383-385, 1995","journal-title":"Int J Cancer"},{"key":"355954_CR18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0277-5379(89)90410-0","volume":"25","author":"R Silvestrini","year":"1989","unstructured":"Silvestrini R, Daidone MG, Valagussa P, Di Fronzo G, Mezzanotte G, Bonadonna G: Cell kinetics as a prognostic indicator in node-negative breast cancer. Eur J Cancer Clin Oncol 25: 1165-1171, 1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"355954_CR19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"147","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Straquet M: Reporting results of cancer treatment. Cancer 147: 207-214, 1981","journal-title":"Cancer"},{"issue":"2","key":"355954_CR20","first-page":"457","volume":"13","author":"FJ Esteva","year":"1999","unstructured":"Esteva FJ, Hortobagyi GN: Locally advanced breast cancer. Adv. Breast Cancer Therapy, Hematology\/Oncology Clinics of North Am 13(2): 457-472, 1999","journal-title":"Adv. Breast Cancer Therapy, Hematology\/Oncology Clinics of North Am"},{"issue":"1Suppl","key":"355954_CR21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cncr.2820741336","volume":"74","author":"CA Perez","year":"1994","unstructured":"Perez CA, Fields JN, Fracasso PM, Philpott G, Soares RL Jr., Taylor ME, Lockett MA, Rush C: Management of locally advanced carcinoma of the breast: II. Inflammatory Carcinoma. Cancer 74(1 Suppl): 466-476, 1994","journal-title":"Cancer"},{"key":"355954_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3835(94)03684-B","volume":"90","author":"GN Hortobagyi","year":"1995","unstructured":"Hortobagyi GN, Buzdar AU, Strom EA, Ames FC, Singletary SE: Primary chemotherapy for early and advanced breast cancer. Cancer Lett 90: 103-109, 1995","journal-title":"Cancer Lett"},{"key":"355954_CR23","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/0959-8049(95)00454-8","volume":"31A","author":"SM Scholl","year":"1995","unstructured":"Scholl SM, Pierga JY, Asselain B, Beuzeboc P, Dorval T, Garcia-Giralt E, Jouve M, Palangie T, Remvikos Y, Durand JC: Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. Eur J Cancer 31A: 1969-1975, 1995","journal-title":"Eur J Cancer"},{"key":"355954_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archsurg.1989.01410010027005","volume":"124","author":"DR McCready","year":"1989","unstructured":"McCready DR, Hortobagyi GN, Kau SW, Smith TL, Buzdar AU, Balch CM: The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg 124: 21-25, 1989","journal-title":"Arch Surg"},{"key":"355954_CR25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.1999.17.2.460","volume":"17","author":"HM Kuerer","year":"1999","unstructured":"Kuerer HM, Newman LA, Smith TL, Ames FC, Hunt KK, Dhingra K, Theriault RL, Singh G, Binkley SM, Sneige N, Buchholz TA, Ross MI, McNeese MD, Buzdar AU, Hortobagyi GN, Singletary SE: Clinical course of breast cancer patients with complete pathological primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17: 460-466, 1999","journal-title":"J Clin Oncol"},{"key":"355954_CR26","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/jnci\/88.20.1456","volume":"88","author":"DF Hayes","year":"1996","unstructured":"Hayes DF, Bast RC, Desch CE, Fritsche H, Kemeny NE, Jessup JM, Locker GY, Macdonald JS, Mennel RG, Norton L, Ravdin P, Sheila T, Winn RJ: Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst 88: 1456-1466, 1996","journal-title":"J Natl Cancer Inst"},{"key":"355954_CR27","first-page":"1193","volume":"121","author":"Canadian Task Force on the Periodic Health Examination","year":"1979","unstructured":"Canadian Task Force on the Periodic Health Examination: The periodic health examination. CanMed Assoc J 121: 1193-254, 1979","journal-title":"CanMed Assoc J"},{"key":"355954_CR28","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1200\/JCO.2000.18.17.3125","volume":"18","author":"D Amadori","year":"2000","unstructured":"Amadori D, Nanni O, Marangolo M, Pacini P, Ravaioli A, Rossi A, Gambi A, Giuseppina C, Perroni D, Scarpi E, Giunchi DC, Tienghi A, Beccioloini A, Volpi A: Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter study. J Clin Oncol 18: 3125-3134, 2000","journal-title":"J Clin Oncol"},{"key":"355954_CR29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1097-0215(19970220)74:1<122::AID-IJC20>3.0.CO;2-G","volume":"74","author":"R Silvestrini","year":"1997","unstructured":"Silvestrini R, Daidone MG, Luisi A, Mastore M, Leutner M, Salvadori B: Cell proliferation in 3800 node-negative breast cancer: consistency over time of biological and clinical information provided by 3H-thymidine labelling index. Int J Cancer 74: 122-127, 1997","journal-title":"Int J Cancer"},{"key":"355954_CR30","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/1097-0142(19891101)64:9<1922::AID-CNCR2820640927>3.0.CO;2-I","volume":"64","author":"A Paradiso","year":"1989","unstructured":"Paradiso A, Tommasi S, Brandi M, Marzullo F, Simone G, Lorusso V, Mangia A, De Lena M: Cell kinetics and hormonal receptor status in inflammatory breast carcinoma: comparison with locally advanced disease. Cancer 64: 1922-1927, 1989","journal-title":"Cancer"},{"key":"355954_CR31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/62.3.513","volume":"62","author":"A Sulkes","year":"1979","unstructured":"Sulkes A, Livingstone RB, Murphy WK: Tritiated thymidine labeling index and response in human breast cancer. J Natl Cancer Inst 62: 513-515, 1979","journal-title":"J Natl Cancer Inst"},{"key":"355954_CR32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1023\/A:1005780107879","volume":"43","author":"D Amadori","year":"1997","unstructured":"Amadori D, Bolpi A, Maltoni R, Nanni O, Amaducci L, Amadori A, Casadei Giunchi D, Vio A, Saragoni A, Silvestrini R: Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: a prospective study. Breast Cancer Res Treat 43: 7-14, 1997","journal-title":"Breast Cancer Res Treat"},{"key":"355954_CR33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00666008","volume":"32","author":"G Gard in","year":"1994","unstructured":"Gard in G, Alama A, Rosso R, Campora E, Repetto L, Pronzato P, Merlini L, Naso C, Camoriano A, Meazza R: Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer. Breast Cancer Res Treat 32: 311-318, 1994","journal-title":"Breast Cancer Res Treat"},{"key":"355954_CR34","first-page":"718","volume":"4","author":"FM Waldman","year":"1991","unstructured":"Waldman FM, Chew K, Ljung BM, Goodson W, Hom J, Duarte LA, Smith HS, Mayall B: A comparison between Bromodeoxyuridine and H3 thymidine labelling in human breast tumors. Mod Pathol 4: 718-722, 1991","journal-title":"Mod Pathol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011956502082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1011956502082\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1011956502082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011956502082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:30:36Z","timestamp":1750480236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1011956502082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["355954"],"URL":"https:\/\/doi.org\/10.1023\/a:1011956502082","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}